Van Oppen, BL, Steketee, G. Individual, group and multifamily cognitive-behavioural treatments. In Current Treatments of Obsessive-Compulsive Disorder (eds Pato, MT, Zohar, J): 133–72. American Psychiatric Press, 1991.
Marks, IM, Hodgson, R, Rachman, S. Treatment of chronic obsessive–compulsive neurosis by in vivo exposure: a two-year follow-up and issues in treatment. Br J Psychiatry
1975; 127: 349–64.
Emmelkamp, PM, Kraaen, J. Therapist-controlled exposure in vivo versus self-controlled exposure in vivo: a comparison with obsessive–compulsive patients. Behav Res Ther
1977; 15: 491–5.
Salkovskis, PM. Obsessional-compulsive problems: a cognitive–behavioural analysis. Behav Res Ther
1985; 23: 571–83.
Rachman, S. A critique of cognitive therapy for anxiety disorders. J Behav Ther Exp Psych
1993; 24: 279–88.
Jones, MK, Menzies, RG. Danger ideation reduction therapy (DIRT): preliminary findings with three obsessive-compulsive washers. Behav Res Ther
1997; 35: 955–60.
Jones, MK, Menzies, RG. Danger ideation reduction therapy (DIRT) for obsessive–compulsive washers. A controlled trial. Behav Res Ther
1998; 36: 959–70.
Krochmalik, A, Jones, MK, Menzies, RG. Danger ideation reduction therapy (DIRT) for treatment-resistant compulsive washing. Behav Res Ther
2001; 39: 897–912.
van Oppen, P, de Haan, E, van Balkom, AJLM, Spinhoven, P, Hoogduin, K, van Dyck, R. Cognitive therapy and exposure in vivo in the treatment of obsessive–compulsive disorder. Behav Res Ther
1995; 33: 379–90.
Emmelkemp, PM, Beens, H. Cognitive therapy with obsessive–compulsive disorder: a comparative evaluation. Behav Res Ther
1991; 29: 293–300.
van Oppen, P, van Balkom, AJLM, de Haan, E, van Dyck, R. Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive–compulsive disorder: a 5-year follow-up. J Clin Psychiatry
2005; 66: 1415–22.
Krone, K, Himle, J, Nesse, R. A standardised behaviour group treatment program for obsessive-compulsive disorder: preliminary outcomes. Behav Res Ther
1991; 23: 627–31.
Fals-Stewart, W, Marks, AP, Shafer, J. A comparison of behavioural group therapy and individual behaviour therapy in treating obsessive–compulsive disorder. J Nerv Ment Dis
1993; 181: 189–93.
Bouvard, M. A standardised cognitive-behavioural group treatment for obsessive–compulsive disorder: preliminary outcomes. Encephale
2002; 28: 439–46.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). APA, 2000.
Goodman, WK, Price, LH, Rasmussen, SA, Mazure, C, Delgado, P, Heniger, GR, et al. The Yale–Brown Obsessive–Compulsive Scale. 1. Development use and reliability. Arch Gen Psych
1989; 46: 1006–11.
Sternberger, LG, Burns, GL. Maudsley Obsessional–Compulsive Inventory: obsessions and compulsions in a non-clinical sample. Behav Res Ther
1990; 28: 337–40.
Marks, IM, Matthew, AM. Brief standard rating for phobic patients. Behav Res Ther
1979; 17: 263–7.
Beck, AT, Steer, RA, Garbin, MG. Psychometric properties of the Beck Depression Inventory: twenty five years of evaluation. Clin Psychol Rev
1988; 8: 77–100.
Beck, AT, Epstein, N, Brown, G. An inventory for measuring anxiety: psychometric properties. J Consult Clin Psychol
1988; 56: 893–7.
de Veaugh-Geiss, J, Landau, P, Katz, R. Preliminary results from a multicentre trial of clomipramine in obsessive-compulsive disorder. Psychopharmac Bull
1989; 25: 36–40.
Braga, DT, Cordioli, AV, Niederauer, K, Manfro, GG. Cognitive–behavioral group therapy for obsessive–compulsive disorder: a 1 year follow-up. Act Psych Scand
2005; 112: 180–6.
Lucey, JV, Butcher, G, Clare, AW, Dinan, TG, et al. The clinical characteristics of patients with obsessive compulsive disorder. A descriptive study of an Irish sample. Ir J Psychol Med
1994; 11: 11–4.